Found 16 Lung Disease trials
A listing of Lung Disease medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Analysis of DRC in lung disease
C
Catherine Sears, MD
The DNA repair capacity (DRC) is a measure of a cell’s ability to repair DNA damage. High levels of DNA damage are observed in many lung diseases, including lung cancer and chronic obstructive lung disease (COPD, sometimes referred to as emphysema or chronic bronchitis). We believe that patients with a …
Rural Telehealth Monitoring in Patients with Interstitial Lung Disease.
R
Ryan Boente
1. To assess the feasibility and utility of a remote monitoring platform for rural ILD patients. 2. To assess adherence and attitudes of rural patients to home spirometry requiring a web application. 3. To determine time spent reviewing the data portal by the medical team.
My Lungs have a pH?
M
Mike Davis
Phase 1
pH is a measurement of acidity. Lung pH, or airway pH, is the measurement of acidity in the lungs and airway specifically. Airway pH varies from person to person, depending on their health. Because of this, IU School of Medicine is collecting an airway pH …
Coping with Cancer-Related Economic Burden
S
Shelley Johns
The purpose of this study is to learn more about the financial burden of cancer treatment, and how it affects patients with cancer. Researchers will use this information to improve support services for patients in the future.
Pathogenesis and molecular mechanisms underlying pulmonary diseases
R
Ryan Boente
C
Chadi Hage, MD
The purpose of this study is to find new ways to detect, treat, and maybe prevent or cure lung diseases.
A Phase II Study of Carboplatin Plus Pemetrexed Plus Atezolizumab Plus Bevacizumab in Chemotherapy and Immunotherapy-naïve Patients With Stage IV Non-squamous Non-small Cell Lung Cancer: Big Ten Cancer Research Consortium BTCRC-LUN17-139
N
Nasser Hanna, MD
The purpose of this study is to estimate the progression free survival (PFS) of the combination of Carboplatin plus Pemetrexed plus Atezolizumab plus Bevacizumab for patients with stage IV non-squamous NSCLC who are chemotherapy and immunotherapy naive.
Circulating Tumor Cells (CTC) in Lung Cancer
J
Jessica MacLean
S
Shadia Jalal, MD
The purpose of this study is to examine rare cells called circulating tumor cells that are present in a person's blood when they have lung cancer to see if there is a relationship between a person's cancer symptoms and the number and characteristics of those cells at various times before …
A Phase II Trial of Chemotherapy plus Pembrolizumab in patients with advanced NSCLC previously treated with PD-1 or PD-L1 Inhibitor
G
Greg Durm, MD
This is a single-arm phase II study of continuation immunotherapy with pembrolizumab following initial benefit with a PD-1 or PD-L1 inhibitor.
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients With Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
S
Shadia Jalal, MD
This randomized phase III trial studies how well erlotinib hydrochloride compared to placebo works in treating patients with stage IB-IIIA non-small cell lung cancer that has been completely removed by surgery.
Adjuvant Nivolumab in Resected Lung Cancers (ANVIL) - A Randomized Phase III Study of Nivolumab After Surgical Resection and Adjuvant Chemotherapy in Non-small Cell Lung Cancers
S
Shadia Jalal, MD
This randomized phase III trial studies how well nivolumab after surgery and chemotherapy work in treating patients with stage IB-IIIA non-small cell lung cancer.
1 - 10 of 16
- 1
- 2
